| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.19M | $7.73M | - | |
| CFO | 589.6K | $2.08M | - | |
| Dir | 204.6K | $722.2K | - | |
| VP | 185.8K | $655.8K | - | |
| Dir | 185.1K | $653.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2017 | Brian Smith | See Remarks | Sale+OE | 9,112 | $20.47 | $186,515.64 | -28.1% | |
| Aug 30, 2017 | Charles W Patrick | Director | Sell | 1,000 | $20.11 | $20,110.00 | -1.9% | |
| Aug 22, 2017 | Brian Smith | See Remarks | Sell | 3,075 | $21.09 | $64,864.00 | -11.6% | |
| Aug 7, 2017 | Jack E Jerrett | SVP & General Counsel | Sale+OE | 73,463 | $20.77 | $1,525,647.82 | -59.9% | |
| Aug 7, 2017 | Anthony Zezzo II | EVP - Infectious Diseases | Sale+OE | 72,916 | $21.26 | $1,550,296.24 | -33.4% | |
| Aug 7, 2017 | Mark L Kuna | SVP & Controller | Sale+OE | 61,959 | $20.49 | $1,269,367.33 | -56.1% | |
| Aug 7, 2017 | Ronald H Spair | COO & CFO | Sale+OE | 510,112 | $20.66 | $10,537,428.47 | -82.4% | |
| Jun 27, 2017 | Douglas A Michels | President & CEO | Sale+OE | 290,495 | $16.75 | $4,866,261.90 | -27.4% | |
| May 31, 2017 | Ronald H Spair | COO & CFO | Sale+OE | 50,000 | $15.06 | $752,890.00 | -31.4% | |
| May 30, 2017 | Charles W Patrick | Director | Sell | 6,666 | $15.15 | $100,989.90 | -11.3% |